News Most doctors in UK think AI training is inadequate A survey has shown that UK doctors think AI can help them save time and expand their capacity to care for patients, but training is lacking.
News AbbVie's ovarian cancer drug Elahere gets NHS green light AbbVie's Elahere has become the first new NHS therapy in more than 20 years for resistant ovarian cancer, providing an alternative to chemotherapy.
News DHSC lauds benefits of single patient record ahead of debate The NHS digital single patient record (SPR) could result in 20,000 fewer A&E visits in England per year and save £20m a year, says the UK government.
News Pharmacy First prescribing expanded to ease GP pressure From the autumn, pharmacists in England will be able to prescribe a wider array of medicines under the Pharmacy First programme.
News Review advises against broad NHS prostate cancer screening The UK's National Screening Committee has concluded that the harms of widespread prostate cancer screening would outweigh its benefits.
News NICE changes stance on Genmab's cervical cancer drug After saying it couldn't recommend Genmab's cervical cancer therapy Tivdak for use by the NHS, reimbursement authority NICE has had a change of heart.
Oncology ASCO 2026: First to first line in HER-2 NSCLC, with Itziar C... At ASCO 2026, BI Global Head of Oncology Itziar Canamasas spoke with pharmaphorum about the company's ASCO data and broader oncology strategy.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.